Corporate brochure
3Pages

Bringing technology within everyone’s reach is a choice. We could have reserved French know-how to developed countries, but we decided to make healthcare available to all; to produce quality and performant reagents and instruments, in France and in Europe, at competitive prices. DID YOU KNOW? That is why we at SFRI do not sell to sell. One of the crucial steps in Healthcare is the We have always had at heart a bigger In Vitro Diagnostics industry. Nowadays, a ambition: to really improve world health. patient’s pathology can be screened, diagnosed, Its approach. Its access. studied and followed all the way, revealing for How to achieve this ambition? example, predispositions to a disease. A treatment’s efficiency can also be First, we rely on the NEOVITEA group which controlled. And all of this, thanks to IVD testing. offers all the skills SFRI needs. hospitals are confirmed by blood tests. These tests are not innocuous, they save lives. Unfortunately, bad instruments or reagents contribute to bad diagnostics. Then we keep listening to our partners, their needs and theirs recommendations. They are the ones in the field. They guide us. Together we grow and work to improve healthcare worldwide. Finally, we stay motivated and keep pioneering. I’m proud to say that during our last annual seminar, my team associated 4 words to SFRI: “Warmth, Adventure, Diversity and Ambition”. This idea is really stimulating for the businessman that I am. We put together our project and decided that SFRI should: “aim to make Healthcare accessible to all” and make sure that we remain “a Human Adventure for Life”. And for that, I know I can count on my dedicated staff to meet any upcoming challenges. We will keep on sharing our know-how, developing our product range and bettering our customer care. My team is experienced, motivated but what’s more, they are confident in SFRI’s future.” Gilles Mougin, NEOVITEA CEO (SFRI’CEO) Marketing In Vitro Diagnostic Medical Devices – like our instruments and reagents – is subject to CE certification. In Europe, the existing directive relevant to the marketing of In Vitro Diagnostic Medical Devices is the 98/79/CE. & ETHICAL QUALITY SYSTEM & STANDARDS Of course SFRI products conform to all these specific standards and each of our reagents are registered with the ANSM, l’Agence Nationale de Sécurité du Médicament – French FDA. SFRI is certified with ISO 13485. This certification provides a standardized method for risk prevention in matters of conception, manufacturing and packaging of medical devices. That is why traceability and management of manufacturing processes are the two pillars of the ISO 13485 certification. By the way, at SFRI, all processes have been put in place so that we can ensure identical quality service to all of our clients. Each contact, request or claim follows strict protocols for the sole purpose of improving our quality of service. PRODUCT QUALITY SFRI has made quality a priority and daily concern. In the whole, the SFRI instrument-reagent system is put through rigorous quality controls all through its life cycle: from development to market. A quality control is much more than a mere formality for us. It is a guarantee of performance, reliability and success. For example: reagents that leave our factory have to go through a minimum of 3 quality controls before being approved for sale, and 100% of our instruments are controlled before being marketed. ECO-RESPONSIBILITY SFRI is a fundamentally responsible company. We have chosen to respect different regulations in favour of sustainable and fair development. This commitment does not come easily, but we have made the choice of building a better future for generations to come, and by signing the United Nations Global Compact Charter SFRI makes that commitment real. As a European company, SFRI also complies with the REACH, WEEE and RoHS regulations. REACH : Registration, Evaluation, Authorisation and Restriction of Chemicals is a European Union regulation adopted to better protect human health and the environment against risks related to chemical substances, all the while favouring competition in the EU chemical market. WEEE & RoHS: Waste Electrical and Electronic Equipment Directive and Restriction of Hazardous Substances are directives that regulate companies selling electrical and electronic products in the European Union. REACH • WEEE • RoHS Non contractual document. Specifications subject to change without notice. Ref. CORPORATE V18.00. Copyright © 2018 SFRI. All rights reserved. «Why shouldn’t small & medium laboratories have access to the same level of quality and precise results as big laboratories?» Finally, saying we are eco-responsible and ethically oriented is one thing, but our clients also needed to see our involvement practically. On a daily basis SFRI orients its preliminary studies towards eco-development and that is how, for example, SFRI came to develop reagents without cyanide. INDUSTRY ORGANIZATIONS SFRI joined both the SIDIV – Syndicat de l’industrie du Diagnostic In Vitro and the EDMA – European Diagnostic Manufacturers Association.

TONS OF REAGENT MANUFACTURED EACH MONTH SOUTHERN EUROPE NORTH AFRICA , logistical and technical supp training ort ucts, Prod > > MIDDLE EAST ASIA INDIAN SUBCONTINENT COMPATIBLE HEMATOLOGY REAGENT REFERENCES SFRI EXPERT SFRI’s spokespersons are more than just distributors. They are our long-term partners in the SFRI adventure. That is why we chose each and every one of our ideal partners with care after a rigorous screening process. To sign a partnership deal with SFRI is to volunteer to be thoroughly trained, accompanied and supervised with the unique purpose of developing skills and a...

Bringing technology within everyone’s reach is a choice. We could have reserved French know-how to developed countries, but we decided to make healthcare available to all; to produce quality and performant reagents and instruments, in France and in Europe, at competitive prices. DID YOU KNOW? That is why we at SFRI do not sell to sell. One of the crucial steps in Healthcare is the We have always had at heart a bigger In Vitro Diagnostics industry. Nowadays, a ambition: to really improve world health. patient’s pathology can be screened, diagnosed, Its approach. Its access. studied and...